Cargando…
Characterisation of IL-23 receptor antagonists and disease relevant mutants using fluorescent probes
Association of single nucleotide polymorphisms in the IL-23 receptor with several auto-inflammatory diseases, led to the heterodimeric receptor and its cytokine-ligand IL-23, becoming important drug targets. Successful antibody-based therapies directed against the cytokine have been licenced and a c...
Autores principales: | Lay, Charles S., Isidro-Llobet, Albert, Kilpatrick, Laura E., Craggs, Peter D., Hill, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199020/ https://www.ncbi.nlm.nih.gov/pubmed/37208328 http://dx.doi.org/10.1038/s41467-023-38541-2 |
Ejemplares similares
-
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET
por: Lay, Charles S., et al.
Publicado: (2022) -
Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
Publicado: (2020) -
Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis
por: Saur, Sebastian-Jonas, et al.
Publicado: (2021) -
A Bimodal Fluorescence-Raman Probe for Cellular Imaging
por: Lin, Jiarun, et al.
Publicado: (2021) -
The use of fluorescence correlation spectroscopy to characterize the molecular mobility of fluorescently labelled G protein-coupled receptors
por: Kilpatrick, Laura E., et al.
Publicado: (2016)